Table 1.

Clinical characteristics and catheterization data between patients with PCWP < 15 mmHg and PCWP > 15 mmHg

Variables (M ± SD)	Group I (Wedge ≤15 mmHg) (N = 35)	Group II (Wedge ≥15 mmHg) (N = 43)	P value
Age	54.26 ± 9.55	52.37 ± 11.88	0.813
NYHA III	25 (71)	20 (58)	0.26
CAD	31 (88)	16 (37.2)	0.521
AF	1 (3)	8(19)	0.05
CKD	15 (26.9)	17 (39.5)	0.004
CRT	14 (40)	10 (23.3)	0.101
ICD	28 (79.5)	35 (81.4)	0.499
COPD	7 (20)	3 (7)	0.405
DM	2 (6)	4 (9)	0. 561
HTN	20 (57)	22 (51)	0.218
NT‐proBNP	2457.62 ± 5367.17	4613.14 ± 4563.44	<0.001
HR	67.11 ± 11.78	73.39 ± 13.95	0.052
SBP	116 ± 17.76	106.6 ± 14.61	0.018
DPB	69.85 ± 11.17	66.14 ± 9.37	0.285
CVP	4.6 ± 2.16	8.86 ± 4.37	<0.001
PAPd	14.14 ± 4.84	27.07 ± 8.12	<0.001
PAPm	17.79 ± 4.9	33.65 ± 7.58	<0.001
PAPs	23.8 ± 5.88	43.16 ± 10.06	<0.001
PCWP	9.57 ± 3.37	24.16 ± 5.09	<0.001
TPG cath	7.91 ± 4.79	9.49 ± 4.36	0.249
PVR (wood unit)	1.8 ± 0.95	2.74 ± 2.53	0.039

AF, atrial fibrillation; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CVP, central venous pressure; DBP, diastolic blood pressure; DM, diabetes mellitus; HR, heart rate; HTN, hypertension; ICD, implatable cardioverter defibrillator; NT‐proBNP, NT‐type pro brain natriuretic peptide; NYHA, New York Heart Association functional class; PAPd, pulmonary artery diastolic pressure; PAPm, pulmonary artery mean pressure; PAPs, pulmonary artery systolic pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance on wood unit; SBP, systolic blood pressure; TPG, transpulmonary gradient.